Inari Medical Acquires LimFlow S.A.

Aileron Therapeutics Acquires Lung Therapeutics

October 31, 2023

Biotechnology

Aileron Therapeutics, Inc. (NASDAQ: ALRN) completed a stock-for-stock acquisition of Lung Therapeutics, Inc., bringing the clinical-stage pulmonary and fibrosis-focused pipeline (including lead candidate LTI-03) into Aileron's portfolio. Immediately after the acquisition Aileron arranged a private placement led by Bios Partners (with participation from Nantahala Capital and others) to raise approximately $18 million to fund ongoing development, including a Phase 1b trial of LTI-03.

VitalHub Acquires Novari Health

July 7, 2025

Healthcare Services

VitalHub Corp. has acquired Novari Health Inc., a Kingston-based provider of patient flow and referral management software, for total up-front consideration of $43.6 million plus potential performance-based consideration (up to $5.0 million earnout). The acquisition strengthens VitalHub's patient-flow and referral management capabilities and is expected to accelerate Novari's international expansion leveraging VitalHub's footprint, particularly in the UK.

LABORIE Medical Technologies Acquires Clinical Innovations for $525M

December 20, 2019

Medical Devices

LABORIE Medical Technologies, a Patricia Industries portfolio company, has completed the acquisition of Clinical Innovations from funds managed by EQT for an enterprise value of $525 million. Clinical Innovations, headquartered in Salt Lake City, Utah, is a leading provider of single-use medical devices for labor & delivery and neonatal intensive care and will form a stand-alone Maternal and Child Health global business unit within LABORIE.

LeMaitre Vascular Acquires Artegraft

June 22, 2020

Medical Devices

LeMaitre Vascular, Inc. acquired the business and assets of Artegraft, Inc. for $90.0 million (including $72.5 million at closing and up to $17.5 million in earnouts). The acquisition adds Artegraft's biologic vascular graft product line (used primarily for hemodialysis access) to LeMaitre's portfolio and will keep Artegraft's North Brunswick, New Jersey manufacturing facility and most employees in place.

JLL Partners Invests in Vascular Technology, Incorporated

June 30, 2025

Medical Devices

JLL Partners, a New York-based middle market private equity firm, has announced an investment in Vascular Technology, Incorporated (VTI), a Nashua, New Hampshire-based medical device company that develops intraoperative Doppler systems and remote suction/irrigation solutions. As part of the transaction JLL partnered with entrepreneur Nilendu Srivastava and the VTI management team and appointed Greg Groenke as CEO and Lars Marcher as Executive Chairman to accelerate product development and market expansion.

Laborie Acquires the JADA® System from Organon

January 28, 2026

Medical Devices

Laborie Medical Technologies has completed the acquisition of the JADA® System and the team behind it from Organon in a transaction announced in late January 2026. The deal — part of Organon’s divestiture program (previously disclosed as up to $465 million) — brings more than 90 employees and an FDA-cleared device for rapid control of postpartum hemorrhage into Laborie’s obstetrics portfolio to expand the company’s maternal health capabilities.